Editorial: Targeting Indoleamine 2,3-dioxygenases and Tryptophan Dioxygenase for Cancer Immunotherapy

• Lieve Brochez,
• Vibeke Kruse,
• Dirk Schadendorf,
• Alexander J. Muller,
• George C. Prendergast

Affiliations

Lieve Brochez

Department of Dermatology, University Hospital Ghent and Cancer Research Institute Ghent (CRIG), Ghent, Belgium

Vibeke Kruse

Department of Medical Oncology, University Hospital Ghent and Cancer Research Institute Ghent (CRIG), Ghent, Belgium

Dirk Schadendorf

Department of Dermatology and Comprehensive Cancer Center, University Hospital Essen, Essen, Germany

Alexander J. Muller

Lankenau Institute for Medical Research, Wynnewood, PA, United States

George C. Prendergast

Lankenau Institute for Medical Research, Wynnewood, PA, United States